The proposed PFS rule also includes other changes that will affect physician, lab, and other reimbursements in 2024 and beyond.
Subscribe today for access to
Articles and Reports
Here’s what to know about the new codes that CMS recently added to the national HCPCS table as well as which ones were removed.
To avoid claims denials and improper billings, ensure billing and coding staff is aware of, and has adjusted to, all recent coding changes.
CMS recently issued long-awaited guidance on post-PHE changes to Medicare coverage of SARS-CoV-2 diagnostic tests.
Here’s a quick briefing of the new codes that come into effect on April 1 that your billing staff should know about.
Even though PAMA has slashed reimbursement rates for many tests, overall Medicare Part B spending on lab tests continues to increase.
According to a recent CMS report, the sheer volume of out-of-network payment disputes is overwhelming the system.
Here’s a look at what labs need to know about the new rules that take effect on Jan. 1 as part of the 2023 Medicare Physician Fee Schedule.
Labs will be able to bill Medicare and Medicaid for these new CLIA-waived tests, starting on April 1, 2023.
The final Outpatient Prospective Payment System Final Rule for 2023 provides for a rate increase of nearly four percent.
Despite Congress’ clear policy on private insurer payment of COVID-19 tests, many labs have been struggling to get reimbursed.
CMS has instructed its MACs to recognize eight new CLIA-waived complexity tests for which labs will be allowed to bill, effective Oct. 1.
As of August 31, 2022, labs and other providers must use the new ABN labeled with the appropriate federal OMB Number (0938-0566) and CMS-R-131 to ensure they can bill Medicare beneficiaries for any lab tests or other services that Medicare doesn’t cover.